What is more, our results suggested that HDAC is might act on the immune networks of lung cancer cells, including changes in the profiles of co-stimulatory molecules, co-stimulatory antigens and cytokines of cancer cells. The gene discussed is HDAC9; the disease is lung carcinoma.